DISCOVERY OF A NOVEL AND POTENT CHOLESTEROL ABSORPTION INHIBITOR AS PROMISING ORALLY ACTIVE LIPID LOWERING DRUG

被引：0
|
作者：
Kanou, M. [1 ]
Nishiwaki, Y. [2 ]
Nakano, A. [2 ]
Yamanaka, Y. [2 ]
机构：
[1] Teijin Pharma Ltd, Pharmaceut Dev Res Labs, Tokyo, Japan
[2] Teijin Pharma Ltd, Pharmaceut Discovery Res Labs, Tokyo, Japan
来源：
ATHEROSCLEROSIS SUPPLEMENTS | 2010年 / 11卷 / 02期
关键词：
D O I：
10.1016/S1567-5688(10)70360-3
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
P293
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [41] Discovery of novel quinoline sulfonamide derivatives as potent, selective and orally active RORγ inverse agonists
    Potin, Dominique
    Amaudrut, Jerome
    Argiriadi, Maria
    Barth, Martine
    Breinlinger, Eric
    Bressac, Didier
    Broqua, Pierre
    Calderwood, David
    Chatar, Mohamed
    Cusack, Kevin
    Gauld, Stephen
    Jacquet, Sebastien
    Kamath, Rajesh
    Lepais, Valerie
    Luccarini, Jean Michel
    Masson, Philippe
    Montalbetti, Christian
    Mounier, Laurent
    Poupardin, Olivia
    Rouaud, Sylvie
    Wallace, Craig
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [42] BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
    Babu, YS
    Chand, P
    Bantia, S
    Kotian, P
    Dehghani, A
    El-Kattan, Y
    Lin, TH
    Hutchison, TL
    Elliott, AJ
    Parker, CD
    Ananth, SL
    Horn, LL
    Laver, GW
    Montgomery, JA
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (19) : 3482 - 3486
  • [43] Metabolism and structure activity data based drug design: Discovery of (-)SCH 53079 an analog of the potent cholesterol absorption inhibitor (-)SCH 48461
    Dugar, S
    Yumibe, N
    Clader, JW
    Vizziano, M
    Huie, K
    VanHeek, M
    Compton, DS
    Davis, HR
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1996, 6 (11) : 1271 - 1274
  • [44] Discovery of a structurally novel, drug-like and potent inhibitor of peptidylarginine deiminase
    Ferretti, Patrizia
    Pong, Kin U.
    Vagaska, Barbora
    Merchant, Rohan
    Matthews, Christopher J.
    Marson, Charles M.
    MEDCHEMCOMM, 2013, 4 (07) : 1109 - 1113
  • [45] A potent and orally active HIV-1 integrase inhibitor
    Egbertson, Melissa S.
    Moritz, H. Marie
    Melamed, Jeffrey Y.
    Han, Wei
    Perlow, Debra S.
    Kuo, Michelle S.
    Embrey, Mark
    Vacca, Joseph P.
    Zrada, Matthew M.
    Cortes, Amanda R.
    Wallace, Audrey
    Leonard, Yvonne
    Hazuda, Daria J.
    Miller, Michael D.
    Felock, Peter J.
    Stillmock, Kara A.
    Witmer, Marc V.
    Schleif, William
    Gabryelski, Lori J.
    Moyer, Gregory
    Ellis, Joan D.
    Jin, Lixia
    Xu, Wei
    Braun, Matthew P.
    Kassahun, Kellem
    Tsou, Nancy N.
    Young, Steven D.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (05) : 1392 - 1398
  • [46] Identification of a novel boronic acid as a potent, selective, and orally active hormone sensitive lipase inhibitor
    Ogiyama, Tomoko
    Yamaguchi, Mitsuhiro
    Kurikawa, Nobuya
    Honzumi, Shoko
    Yamamoto, Yuka
    Sugiyama, Daisuke
    Inoue, Shinichi
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (16) : 3801 - 3807
  • [47] Pharmacological profile of SB939, a novel, potent and orally active histone deacetylase inhibitor
    Sangthongpitag, K.
    Wu, X.
    Khng, H.
    Goh, S.
    Ng, P.
    Hu, C.
    Bonday, Z.
    Wang, H.
    Wood, J.
    Entzeroth, M.
    EJC SUPPLEMENTS, 2006, 4 (12): : 52 - 52
  • [48] Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened
    Munchhof, Michael J.
    Li, Qifang
    Shavnya, Andrei
    Borzillo, Gary V.
    Boyden, Tracey L.
    Jones, Christopher S.
    LaGreca, Susan D.
    Martinez-Alsina, Luis
    Patel, Nandini
    Pelletier, Kathleen
    Reiter, Larry A.
    Robbins, Michael D.
    Tkalcevic, George T.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (02): : 106 - 111
  • [49] Blood pressure lowering with SPP100, a novel orally active renin inhibitor - A pilot study
    Stanton, AV
    Mann, J
    Jensen, C
    O'Brien, ET
    HYPERTENSION, 2001, 38 (03) : 526 - 526
  • [50] Discovery and Evaluation of Pyrazolo[3,4-d]pyridazinone as a Potent and Orally Active Irreversible BTK Inhibitor
    Zhang, Xuejun
    Sheng, Xijun
    Shen, Jie
    Zhang, Shoubo
    Sun, Wenjie
    Shen, Chunli
    Li, Yi
    Wang, Jun
    Lv, Huqiang
    Cui, Minghui
    Zhu, Yuchuan
    Huang, Lei
    Hao, Dongling
    Qi, Zhibo
    Sun, Guanglong
    Mao, Weifeng
    Pan, Yan
    Shen, Liang
    Li, Xin
    Hu, Guoping
    Gong, Zhen
    Han, Shuhua
    Li, Jian
    Chen, Shuhui
    Tu, Ronghua
    Wang, Xuehai
    Wu, Chengde
    ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (10): : 1863 - 1868
12345